BindingDB logo
myBDB logout

BDBM332496 4-(1-{[2-chloro-6- (trifluoromethyl) phenyl]carbonyl}-6- pyridin-4-yl-1H-indazol- 3-yl)benzoic acid::US10196354, Example 23B::US9745265, 23B

SMILES: OC(=O)c1ccc(cc1)-c1nn(C(=O)c2c(Cl)cccc2C(F)(F)F)c2cc(ccc12)-c1ccncc1

InChI Key: InChIKey=UUUDMJKDJAOEQW-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 332496   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nuclear receptor ROR-gamma


(Mus musculus)
BDBM332496
PNG
(4-(1-{[2-chloro-6- (trifluoromethyl) phenyl]carbon...)
Show SMILES OC(=O)c1ccc(cc1)-c1nn(C(=O)c2c(Cl)cccc2C(F)(F)F)c2cc(ccc12)-c1ccncc1
Show InChI InChI=1S/C27H15ClF3N3O3/c28-21-3-1-2-20(27(29,30)31)23(21)25(35)34-22-14-18(15-10-12-32-13-11-15)8-9-19(22)24(33-34)16-4-6-17(7-5-16)26(36)37/h1-14H,(H,36,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...


US Patent US9745265 (2017)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma


(Homo sapiens (Human))
BDBM332496
PNG
(4-(1-{[2-chloro-6- (trifluoromethyl) phenyl]carbon...)
Show SMILES OC(=O)c1ccc(cc1)-c1nn(C(=O)c2c(Cl)cccc2C(F)(F)F)c2cc(ccc12)-c1ccncc1
Show InChI InChI=1S/C27H15ClF3N3O3/c28-21-3-1-2-20(27(29,30)31)23(21)25(35)34-22-14-18(15-10-12-32-13-11-15)8-9-19(22)24(33-34)16-4-6-17(7-5-16)26(36)37/h1-14H,(H,36,37)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...


US Patent US10196354 (2019)

More data for this
Ligand-Target Pair